DuPont de Nemours, Inc. (DD) is a publicly traded company in the Basic Materials — Chemicals industry listed on NYSE. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.
DuPont de Nemours, Inc. is a global provider of advanced materials and innovative solutions, serving markets across North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific region. The company's operations are organized into three primary segments: Electronics & Industrial, Mobility & Materials, and Water & Protection. The Electronics & Industrial division focuses on supplying critical materials and advanced systems.
Is DuPont de Nemours, Inc. stock overvalued or undervalued in 2026?
DuPont de Nemours, Inc. (DD) trades at 311× earnings (P/E), against a median of 18.8× across the 156 materials companies above $2bn in Kaplio's universe. It trades at 11.5 times its average earnings over ten years; between the 10 times Lynch paid for a cyclical and the 25 of Graham's limit for the defensive investor, it is fairly priced.
Kaplio overview: DuPont de Nemours, Inc.
Market cap $19B · 52 weeks $102 – $155 (9 % below the high) · P/E 311× · 2027 expected P/E 17.5× · Dividend 1.7 % · Next earnings November 3, 2026 · expected EPS $1.87 · Closing price, Oct 30 · accounts published Aug 4.
- Valuation: P/E 311.2× (fairly priced).
- Business: ROIC 5 % (weak).
- Balance sheet: Net debt/EBITDA 2.1× (solid).
- Earnings: 8 of 8 (uneven).
It trades at 11.5 times its average earnings over ten years; between the 10 times Lynch paid for a cyclical and the 25 of Graham's limit for the defensive investor, it is fairly priced.
What matters in materials: 4 of 8 pass
- FCF yield 5.8 %, fails.
- Capex / D&A 0.5×, fails.
- Altman Z-Score 0.4, fails.
- Cycle-adjusted EV/EBITDA 13.5×, fails.
- Gross margin 30.3 %, passes, near the threshold.
- Net debt / EBITDA (trough) 2.1×, passes.
- Dividend coverage 1.8×, passes.
- P/B across cycles 1.4×, passes.
Against its peers (reference peers) — DuPont de Nemours, Inc.: P/E —; EV/EBITDA 13.5×; ROIC 4.9 %; $18.9B. Dow Inc. (P/E —; EV/EBITDA 11.4×; ROIC 1.1 %; $25.1B), Celanese Corporation (P/E —; EV/EBITDA 42.5×; ROIC -3.8 %; $5.4B), LyondellBasell Industries N.V. (P/E 41.6×; EV/EBITDA 10.7×; ROIC -36.4 %; $22.2B).
Dividend
tight (only raised recently) · Yield 1.7 % ($4.29 per share in 2025) · 5-year growth +4 % a year · Free cash flow coverage 2.1× · With $1,000 invested today you'd collect $17.10 a year ($1.43 a month).
Kaplio's reading: DuPont de Nemours, Inc.
Updated on October 31, 2026 · accounts published on August 4, 2026
A materials business with steady operating margins
DuPont de Nemours trades at a P/E of 311.2 over the last 12 months, 1,555 % above its sector median of 18.8, after EPS fell 211 %.
- Is DuPont de Nemours expensive or cheap? Its P/E of 311.2 sits 1,555 % above the 18.8 sector median over the last 12 months; EV/EBITDA of 13.5× is less extreme.
- How is the business doing? Revenue fell 45 % over the last 12 months, yet the 14.7 % operating margin beats the 12.9 % average of 2014-2025.
- How strong is the balance sheet? Net debt was $19.76 per share in fiscal 2025, 14 % of the share price and 2.1× EBITDA, below the 3.0× sector ceiling.
- Can the balance sheet hold up through the bottom of the cycle? Capex ran at 0.5× depreciation in fiscal 2025, below the 0.8× to 1.5× range the sector considers healthy.
- What to expect from the next earnings? Analysts expect EPS of $1.87 on November 3, 2026, after 8 beats in the last 8 quarters.
Is DuPont de Nemours expensive or cheap?
DuPont de Nemours trades at a P/E of 311.2 over the last 12 months, 1,555 % above the 18.8 median of 156 sector peers. A net margin of just 0.7 % inflates that multiple, so it reflects depressed earnings more than a rich price. EV/EBITDA of 13.5× is a cleaner gauge. It sits above the company's six-year average of 10.7× and past the 110 % threshold the sector uses to flag expensive. Price to book of 1.4× stays under the 2.0× considered reasonable for materials. The stock is up 39 % over 12 months and trades 9 % below its 52-week high of $154.59.
How is the business doing?
Over the last 12 months revenue shrank 45 % and EPS fell 211 %, so today's figures come from a much smaller business than a year ago. Operating profitability has held up. The operating margin of 14.7 % over the last 12 months compares with 12.6 % in fiscal 2025 and a 12.9 % average across 2014-2025. Little of that reaches shareholders: the net margin is 0.7 % and ROE is 0.3 %. ROIC of 4.9 % is 4.4 points below the 9.2 % sector median, and it has not cleared 10 % in any of the last ten fiscal years.
How strong is the balance sheet?
Conventional leverage looks moderate. Over the last 12 months debt to equity was 0.23 and the current ratio was 2.43. In fiscal 2025 net debt stood at 2.1× EBITDA, comfortably below the 3.0× the sector treats as healthy. The dividend yields 1.7 %, and in fiscal 2025 free cash flow covered it 1.8×, above the healthy floor of 1.3×. The warning comes from an Altman Z score of 0.4 over the last 12 months, deep in the danger zone below 1.81. The score leans heavily on earnings and returns, and both are weak today. Piotroski sits at a middling 5 of 9.
Can the balance sheet hold up through the bottom of the cycle?
Materials companies move with commodity cycles, so a P/E built on a single year says little. Cost position, cash generation and dividend sustainability matter more. DuPont de Nemours passes four of these sector checks: gross margin of 30.3 % in fiscal 2025, net debt at 2.1× EBITDA, dividend cover of 1.8× and price to book of 1.4×. It fails on free cash flow yield (5.8 % over the last 12 months against an 8 % bar), cycle-adjusted EV/EBITDA and Altman Z. Capex at 0.5× depreciation in fiscal 2025 flatters today's free cash flow. If spending stays below asset wear for long, the asset base ages.
What to expect from the next earnings?
DuPont de Nemours reports on November 3, 2026. Analysts are looking for EPS of $1.87, close to the $1.88 it delivered on August 4, 2026, when it beat the $1.76 estimate by 7 %. It has topped EPS estimates in 8 of the last 8 quarters, so the market is used to beats. Over the last 30 days the 2026 EPS consensus barely moved, from $7.25 to $7.26 across 9 analysts, and revenue forecasts were also flat. Of the 41 analysts covering the company, 24 recommend buying, 16 holding and 1 selling.
How this was prepared: the data comes from companies' official filings, collected by a professional provider, and from Kaplio's analysis engine (trailing-12-month ratios, 10 years of history and sector medians computed across US-listed companies). The text is written from that data alone, every figure is checked against it before publication, and it is reviewed when the company reports results. This is not investment advice.
Investor methods verdict
Would Peter Lynch approve DuPont de Nemours today?
The Lynch Method approves DuPont de Nemours today. Business quality: 100 out of 100 (price not included). Lynch classifies it as a turnaround. Kaplio assessment with data from the week of 2026-10-26; not investment advice.
Profitability
| Return on Equity | 0.34% |
| Return on Invested Capital | 4.88% |
| Return on Assets | 0.26% |
| Gross Margin | 34.39% |
| Operating Margin | 14.71% |
| Net Margin | 0.67% |
Financial Health
| Debt / Equity | 0.23 |
| Current Ratio | 2.43 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 0.40 |
Price Performance
| 1 month | +8.40% |
| 3 months | +2.23% |
| Year-to-date | +16.13% |
| 1 year | +36.70% |
| 3 years | +66.73% |
| 5 years | +56.66% |
| 10 years | +46.30% |
Dividend History
Paid in the last 12 months: $2.4000 per share in 4 payments.
| Date | Amount |
|---|---|
| 2026-11-30 | $0.6000 |
| 2026-08-31 | $0.6000 |
| 2026-05-15 | $0.6000 |
| 2026-03-02 | $0.6000 |
| 2025-11-28 | $0.6000 |
| 2025-08-29 | $0.5144 |
| 2025-05-30 | $0.5144 |
| 2025-03-03 | $0.5144 |
| 2024-11-29 | $0.4768 |
| 2024-08-30 | $0.4768 |
Amounts adjusted for stock splits.
Related companies: MMM · DOW · LYB · ESI · EMN · CE · AVNT · CC
Explore sector: Basic Materials · Chemicals
More sections of DD: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks